Cullinan Therapeutics Inc - Wutah bathi EPS kuartalan CGEM

Logo korporat perusahaan Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics (CGEM) holds unique patents that protect its developments from competitors despite strict FDA oversight. The quarterly EPS growth rate on the GURU.Markets consolidated chart shows that the latest parameter is 10.80. However, cold chain complexities in biologic deliveries and the high intensity of R&D pipeline updates toward autoimmune pathologies create significant risks.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan cullinanoncology.com (CGEM): kanggo periode 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Cullinan Therapeutics

Pambiji fundamental perusahaan:cullinanoncology.com - CGEM
Barang unggulan cullinanoncology.com

Quarterly EPS growth reflects the dynamics of net income per share relative to previous periods. This metric is calculated by comparing operating margins and revenue growth rates to exclude the impact of one-time cost reductions. By analyzing the history of quarterly earnings per share changes, an investor determines the feasibility of business scaling. For Cullinan Therapeutics (CGEM), such a metric is critical during the development of bispecific antibodies, as it confirms the company's financial stability amidst fierce scientific competition with pharma behemoths.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Tyra Biosciences|VSTM (Verastem, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|GLUE: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|IMRX (immuneering.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan C4 Tx CCCC|Wutah bathi EPS kuartalan BDTX|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)